Get started
UNITEDHEALTHDRNUNITEDHEALTHDRNUNITEDHEALTHDRN

UNITEDHEALTHDRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

UNHH34 trade ideas

UNH: Knife or Generational Opportunity?News today that NYSE:UNH suspended 2025 guidance and CEO stepped down led to a massive route... right down to the 50% Retracement from the 2008 bottom to the former All Time High. This is potentially a big opportunity for a long term position at this level: 322. I would have preferred the level to be matched by a Volume Profile level but the nearest one below is at 244. I can still see a good risk adjusted trade back to the median of the down move initially and onward to a full recovery. I took a moderate position in tax advantaged accounts for the long term hold and will keep an eye on this level for a more tactical setup (a spike or further price action to confirm the hold).
NYSE:UNHLong
by norok
11
Life Time Opportunity Trade Setup NYSE:UNH Entry Price: $280 (at market open) Profit Target: $400 Stop Loss: $250 Risk-Reward Ratio: 4.3:1 Position Size: 1% of portfolio Why Bullish? UNH is trading near a 5-year low ($248.88) after a -50% drop in a month, driven by a DOJ Medicare fraud probe and CEO change. Despite the noise, analysts are bullish with 55 Buy ratings and a $445-$460 target, pointing to undervaluation (forward P/E ~10x). Institutional buying (Viking Global +12.5% stake) and a low VIX (17.83) support a potential rebound. Key Catalysts Technicals: Near 52-week low, RSI oversold, potential reversal. Fundamentals: $400B revenue, 15% EPS growth projected long-term. News: DOJ probe and suspended 2025 guidance weigh, but analysts see overreaction. Macro: VIX at 17.83 (stable), 10-year yields at 4.424% (headwind). Risks Ongoing DOJ investigation could escalate. Rising medical costs and volatile sentiment. Further downside if support at $250 breaks. Chart Notes UNH testing major support at $250-$270. Volume spikes on selling, but capitulation may signal a bottom. Watch for a break above $300 to confirm bullish momentum. Keep your long term vision Follow for the Best AI generated Signals on the market Ash.
NYSE:UNHLong
by AlphaSignals_ai
12
UNH: Short OTM puts expiring May 23UNH bounced from the $248.88 low and will probably not hit new low the following week. IV was relative high due to volatile stock price movement. Hence, setting up naked shorts on OTM puts. Max potential profits: $1,000+ premiums on May 23 Exit strategy: buy back gradually if UNH price crosses down $240 to secure positive results; otherwise, close all on May 23 Instrument Entry Date UNH 23MAY25 200P 2025-05-15 UNH 23MAY25 210P 2025-05-16 UNH 23MAY25 225P 2025-05-16 ========== STATS ========== Number of traded instruments YTD: 20 P/L YTD: $2K Win rate: 100%
NYSE:UNHShort
by SteadyGainsCA
1
$UNH: With stock down more than 60%, is it in buy zone? NYSE:UNH with one after bad news lost 60% of its market cap from its ATH of 600$. NYSE:UNH the largest insurer in US has been in news for all the wrong reasons. The stock after losing 60% of the value has a dividend yield of 3.1% which is 2.5 times of the S&P Yield. The historical dividend growth of NYSE:UNH has been more than 8%. This makes NYSE:UNH a compelling story stock during the recent downturn. With recent insider buys of the NYSE:UNH stock most of the fundamental indicators indicate a positive outlook. But what are the technical indicators telling us? Today we are looking at the historical chart of the stock. The last time the stock was down more than 60% was during the 2007-2008 Financial recession. In 2008 it did lose more than 64%. If we investigate the long term RSI then we see it below 25 which we also saw last during the Financial recession. Verdict : Buy 1/3 @ 250, Buy 1/3 @ 275, Buy 1/3 now.
NYSE:UNHLong
by RabishankarBiswal
1
UNH is a Great Opportunity Following Panic Sell-Off UNH remains a solid business with a great potential upside. The recent drop was driven by softer financials, CEO resignation, and a DOJ probe—more fear than fundamentals. Core operations are stable. Valuation is now attractive, making this a solid entry point for patient investors. Many argue that UNH is just an insurance business, not a tech company. They are wrong. UNH holds a massive amount of healthcare data that can be leveraged for insights, efficiency, and innovation. This data is not just an asset—it is a moat that few competitors can replicate. The recent insider buying is a green flag ! a signal for investors that there are no skelatons in the closet On the chart, increasing green volume supports bullish sentiment. The 10-day EMA has crossed above the 20-day EMA on the hourly timeframe, indicating short-term upward momentum. Additionally, the MACD is turning positive indicating less fear and more greed!, and RSI is trending higher—both pointing to strengthening buying pressure.
NYSE:UNHLong
by Missmoyeu
1
UNH | Catching the Fall Risky Play💊 Oversold Swing Play ⚠️ Risk Factor You're not trading a bounce—you’re stepping into a fire. Legal risk + uncertainty = extreme volatility. However, if markets stabilize, UNH could deliver a powerful mean-reversion move. UnitedHealth ( NYSE:UNH ) is trading in panic territory after: DOJ launched a criminal probe tied to Medicare Advantage billing Abrupt CEO resignation Suspended 2025 financial guidance, sparking investor selloff Still, the fundamentals aren’t dead. Q1 revenue is strong, and long-term value is on the table. 🎯 Trade Plan 🟢 Entry Zones 🔹 Zone 1: $275–$285 → Technical support + RSI oversold 🔹 Zone 2: $255 → 2021 breakout retest 🔹 Zone 3: $225 → Ultimate fear zone (deep capitulation possible) 💰 Profit Targets ✅ TP1: $300 – Psychological level & minor resistance ✅ TP2: $340 – Gap-fill area & 50-day MA ✅ TP3: $385+ – Long-term value zone if sentiment reverses 📌 Final Word UNH is no penny stock—it’s a $280B giant under siege. If you believe fear is overdone, this is a calculated shot at a rebound. Just keep your stops tight and your thesis tighter. 🚨 Disclaimer: This is not financial advice. Trading involves risk. Always DYOR and manage your exposure carefully.
NYSE:UNHLong
by Robert_V12
2
5/15/25 - $unh - I'll comment.5/15/25 :: VROCKSTAR :: NYSE:UNH I'll comment. - as a rule, i typically avoid companies that have credible issues associated with frauds. we all know UNH committed some pretty heinous crimes against humanity - institutions that want to buy this thing at $250 are probably getting massive pushback from their risk teams today and being told "fine don't sell as much" (even tho they r going to be forced to trim), but no add. - so any bid here comes from a headline (real or fake). add to this you have 5/16 opex tmr, this ticker isn't an insignificant mcap and so index and flows work against it at the mgn. furthermore, any statement forthcoming perhaps doesn't hit until next week? i mean... the mgmt team is running or getting *squashed*. lawyers r not going to push for immediate statements here bc *muh stock price* - options chain pretty solid around $250. stock probably doesn't have a ton left to go here. - IFFFFFF i were to trade this long, i'd probably wait for an abysmal close. and a red open. and i'd punt on some call spreads next week. let's see. but given NXT and GAMB today that r keeping me busy... i have zero interest to complicate my life. idk if that helps but i've gotten a lot of DMs oh on valuation... there's no "E" we can stand on here. so realistically this could easily trade at single digit PE on re-rated expectations which is another 25% lower... keep that in mind. this won't be a V shaped recovery trade. so timing/ and paying VERY close attention is what's required to get an edge/ make risk-adj. $. just not my cup of tea. oh - and F the crooks here. we all know u r guilty. V
NYSE:UNH
by VROCKSTAR
2
- UNH Down 38.2%—Are Buyers Ready to Step In?- "Healthcare Stocks at Higher Timeframe Support (Golden Ratio) —Bounce Incoming?" Key Reasons for UNH’s Stock Decline ✅ CEO Resignation → Andrew Witty stepped down for personal reasons, and former CEO Stephen Hemsley returned to stabilize the company. ✅ Suspended 2025 Outlook → UNH withdrew its financial guidance, citing higher-than-expected medical costs from new Medicare Advantage members. ✅ Regulatory Scrutiny → The DOJ is investigating UNH for possible Medicare fraud, adding uncertainty. ✅ Cybersecurity Breach → A massive data breach at its subsidiary Change Healthcare affected 190 million records, disrupting operations. ✅ Stock Market Reaction → UNH shares plummeted 16% in a single day, marking their lowest level in nearly five years. 🔹 Future Outlook Despite setbacks, UNH remains a dominant player in healthcare, with over 50 million insured members. Analysts believe the company can recover under Hemsley’s leadership, but short-term volatility remains high. United Health Group (UNH) trading at 250$ 0.618 F5 Support ( Golden Ratio ) Anticipating buyers to come in at this level. XLV. The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund (ETF) that tracks the healthcare sector within the S&P 500. It includes companies from pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. This sector is trading near Weekly Support Nodes Weekly OP + Weekly F3 nodes or Weekly OP F3 Agreement Its also Oversold. ELV - Elevance Health Inc, one of the main competitors to UNH in this space trading at Weekly F3 Support ( 0.382 retracement ) + Weekly Oversold Given UNH, ELV and the broader sector, XLV, are all trading at important Higher Timeframe Support nodes... with UNH down 20% today at one point, and down 38.2% from its highs ( largely within a month ) Looking for a Technical Bounce against Higher Timeframe Support nodes, on UNH, and the sector. "Will we see a bounce at these levels? Drop your thoughts below!" - Joseph AuXano #UNH #XLV #HealthcareStocks #TradingView
NYSE:UNHLong
by JosephAuxano
2
UNH and DOJ. What has ever happened? Value stock Back with another freebie for the followers. I am not getting enough love after the freebies and multibaggers I have thrown at the community. UNH. Investigations, fraud, malpractices. Does that change the fact that it is the biggest health insurer in the USA? People reading this might be insured with UNH. What have investigations ever brought the USA? A slap on the wrist, a fine and some low key employee fired. Does that change your insurance? Does that wipe out 100+ billion from UNH balance sheet? NO A value stock for a value investor. The Foxx announces a position of 10000 stocks of UNH @284.1 post market 19:35 on May 14 2025. Happy to average down till it goes to 1. That is conviction. Bill ackman who? Follow the Foxx, throw some love in the comments, and ill maybe throw another bone for yall soon..
NYSE:UNH
by FoxxInvest
Generational Buy - Congratulations Well done to those that bought the dip on this below $300. I filled 80% of my position at $250 - the Point of Control according to the highest volume node. We had a capitulation in the top healthcare insurer. Absolute peak fear given the long list of events which culminated in the CEO leaving. His departure could have been the final flush out as holders capitulated. This presented a unique opportunity to get in on an undervalued stock trading at a P/E of 11.1. I’m a trader, so I won’t comment on the ethics of this company, it’s beyond the scope of my work. Technically I expect this relief rally to continue but in a corrective fashion with a potential resistance level looming. The 5th wave ending is normally followed by an abc correction, wave A has concluded, wave B is in play so I expect onward bullish recovery. For confluence, the weekly RSI had a complete reset hitting level of 30, the most oversold in many years. My indicator has flashed green (buy) so $250 could have been a generational low. None of this is financial advice, I got in at a good entry and I have a stop loss in place if this poops the bed again.
NYSE:UNHLong
by NoFOMO_
UnitedHealth Group | UNH | Long at $323.00UnitedHealth Group NYSE:UNH currently has a P/E near 15x, steady rising revenue (2024 = $400+ billion), EPS of 6.24x, dividend of 2.2%, and earnings are forecast to grow by 10.8% per year. The stock, however, has plummeted recently due to negative news, rising healthcare costs, CEO changes, and suspension of 2025 outlook. Every company has bumps, but I view solid companies like NYSE:UNH as pure opportunities for long-term investment - especially with America's aging population. From a technical analysis perspective, the stock price has entered my "crash" simple moving average zone (which currently extends down near $307.00). Personally, this is the zone I am starting a position due to the odds of a future bounce from here. However, I am very aware that there is an open price gap near $265.00 that may get filled this year or early next. I could see a bounce in my crash zone to bring in the bulls and then a drop to that level to heighten the fear. That is another area I plan to grab more shares and build a strong position. But, in case it doesn't extend that low, I have started a position at $223.00, with future investments near $307.00 and below. I doubt this will be a quick turnaround stock - patience is where money is made. Targets (into 2028): $375.00 $475.00 $580.00
NYSE:UNHLong
by WorthlessViews
UnitedHealth UNH - Institutional Exit or Long-Term Opportunity?Key Insights UNH has witnessed a historic -24% monthly drop, breaking multiple key long-term supports on extreme volume — often a sign of institutional distribution or capitulation. Bearish Outlook (Primary Bias): Current price is testing the 0.5 Fibonacci retracement ($322 - $287), a critical make-or-break zone. A monthly close below $287 will likely trigger the next leg lower toward $250 and possibly the $200 psychological handle. The bearish momentum remains dominant, confirmed by RSI deep in bear territory and MACD accelerating down. Invalidation Levels (For Shorts): Aggressive short invalidation: Weekly close above $395.33. Full bearish invalidation (shift to bullish bias): Monthly close above $447.21. Bullish Opportunity Zones: Watch for strong bullish reversal at the $287 - $249 support zone, aligning with 0.382 Fib and historical demand. If $200 - $160 is ever reached, it becomes a high-probability accumulation zone for long-term investors. Probability: $395 - $447 Strong Short Bias , Look for retests & rejection $322 - $287 Neutral to Bearish (watch reaction), Currently testing key support $249 - $200 High-Probability Long Setup, Look for confirmation reversal Above $447.21 Bullish Bias Resumes, Invalidate bears, shift to longs Conclusion: UNH is at a critical long-term support crossroad. Patience is key—traders should avoid chasing the lows and wait for higher-probability setups at key levels. Let the chart guide the trade
NYSE:UNH
by truthseeker6
UNH can retrace the fib and come back to the lowSee trading is all about risk and probability. There is news flowing left and right about insiders buying UNH for the dip, a director bought about $1m single handedly. But remember, DOJ is serious about the Medicare Fraud Probe. I believe since there is a huge, huge downfall from April 16, 2025... there will definitely be a retracement, but not till .5 or .618, imo. So after retracement to 381 range, it may again fall down to 250 low ( as rapid downfall, suggests retracement to only 0.38 range, from my personal experience). Huge Volume spike is also seen stating a lot of people are being involved in this stock. Some may try to get rid off it as soon as possible, some might speculate the comeback of UNH to 594 normal range.
NYSE:UNHShort
by FinExcel
UnitedHealth (UNH) Share Price ReboundsUnitedHealth (UNH) Share Price Rebounds A month ago, in our analysis of the UNH chart, we: → highlighted that UnitedHealth shares had lost nearly 23% in value; → drew a descending channel and suggested that bearish pressure could continue, threatening the support level around $450, which had held since early 2022. Since then, UNH’s stock price decisively broke below that level (as marked by the arrow), falling to around $250 — its lowest point since spring 2020 — before staging a sharp rebound. This steep price movement was driven by a series of fundamental developments, including: → the resignation of the CEO and news of a Department of Justice investigation into potential Medicare fraud; → UnitedHealth withdrawing its earnings guidance for the coming year; → political debates over the Medicaid programme as part of the 2025 budget negotiations; → President Trump’s directive to cut prescription drug prices. Recent news that the new CEO and several top executives have bought tens of millions of dollars’ worth of UNH shares appears to have renewed investor confidence — the share price rose above the $300 mark yesterday. Technical Analysis of UNH Share Chart These latest developments justify an update to the descending channel configuration. Of particular note is the gradual decline with limited volatility — a sign that the price is moving along the channel's median line (highlighted on the chart). In this setup: → the bounce from the $250 level points to the lower boundary of the channel; → traders may consider a scenario where the current recovery pushes UnitedHealth stock towards the median, after which supply pressure may return and offset the recent dominance of demand. It’s also possible that the key psychological level of $300 could now act as support. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen